SCYNEXIS Inc
SCYX0.702USD
+0.021+3.11%
交易中 （美东）报价延迟15分钟
27.40M总市值
亏损市盈率 TTM
关于 SCYNEXIS Inc 公司
SCYNEXIS, Inc. 是一家生物技术公司。该公司是治疗和预防难治性感染和耐药性感染的先驱药物。该公司开发了抗真菌平台 fungerps，这是一种新型抗真菌剂，称为三萜类化合物，是结构独特的葡聚糖合酶抑制剂，在体外和体内均表现出对抗一系列人类真菌病原体的活性，例如念珠菌属和曲霉菌属（包括耐多药菌株）以及肺孢子菌、球孢子菌、组织胞浆菌和芽生菌属以及常见的毛霉菌种。Ibrexafungerp 是此类新型抗真菌剂的首个代表，此外还有 fungerp 家族的其他资产，包括 SCY-247，目前正处于临床前开发阶段。美国食品药品监督管理局批准 BREXAFEMME 用于治疗外阴阴道念珠菌病（也称为阴道酵母菌感染）患者，并降低复发性外阴阴道念珠菌病的发病率。
公司简介
公司代码SCYX
公司名称SCYNEXIS Inc
上市日期May 02, 2014
CEODr. David Angulo, M.D.
员工数量28
证券类型Ordinary Share
年结日May 02
公司地址1 Evertrust Plaza
城市JERSEY CITY
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编07302-6548
电话12018845485
网址https://www.scynexis.com/
公司代码SCYX
上市日期May 02, 2014
CEODr. David Angulo, M.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Ivor Macleod, CPA
Mr. Ivor Macleod, CPA
Chief Financial Officer
Chief Financial Officer
71.40K
-30.69%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
55.00K
+71.88%
Mr. Armando Anido
Mr. Armando Anido
Independent Director
Independent Director
48.00K
+92.00%
Dr. Steven C. Gilman, Ph.D.
Dr. Steven C. Gilman, Ph.D.
Independent Director
Independent Director
47.00K
+95.83%
Dr. Ann F. Hanham, Ph.D.
Dr. Ann F. Hanham, Ph.D.
Independent Director
Independent Director
46.62K
+97.37%
Mr. David C. Hastings
Mr. David C. Hastings
Independent Director
Independent Director
46.18K
+99.21%
Mr. Scott A. Sukenick, J.D.
Mr. Scott A. Sukenick, J.D.
Chief Legal Officer, General Counsel
Chief Legal Officer, General Counsel
--
--
Ms. Irina Koffler
Ms. Irina Koffler
Investor Relations
Investor Relations
--
--
Dr. David Angulo, M.D.
Dr. David Angulo, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Philippe Tinmouth
Mr. Philippe Tinmouth
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Ivor Macleod, CPA
Mr. Ivor Macleod, CPA
Chief Financial Officer
Chief Financial Officer
71.40K
-30.69%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
55.00K
+71.88%
Mr. Armando Anido
Mr. Armando Anido
Independent Director
Independent Director
48.00K
+92.00%
Dr. Steven C. Gilman, Ph.D.
Dr. Steven C. Gilman, Ph.D.
Independent Director
Independent Director
47.00K
+95.83%
Dr. Ann F. Hanham, Ph.D.
Dr. Ann F. Hanham, Ph.D.
Independent Director
Independent Director
46.62K
+97.37%
Mr. David C. Hastings
Mr. David C. Hastings
Independent Director
Independent Director
46.18K
+99.21%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
Federated Hermes Global Investment Management Corp.
7.42%
Kingdon Capital Management, L.L.C.
5.73%
The Vanguard Group, Inc.
4.25%
Avidity Partners Management LP
3.15%
AMH Equity, Ltd.
1.61%
Other
77.85%
持股股东
持股股东
占比
Federated Hermes Global Investment Management Corp.
7.42%
Kingdon Capital Management, L.L.C.
5.73%
The Vanguard Group, Inc.
4.25%
Avidity Partners Management LP
3.15%
AMH Equity, Ltd.
1.61%
Other
77.85%
股东类型
持股股东
占比
Hedge Fund
11.22%
Investment Advisor/Hedge Fund
10.55%
Investment Advisor
8.01%
Individual Investor
2.24%
Research Firm
0.08%
Venture Capital
0.06%
Bank and Trust
0.01%
Other
67.84%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
120
12.60M
32.29%
-2.78M
2025Q1
133
12.41M
31.82%
-4.90M
2024Q4
136
12.64M
33.32%
-10.36M
2024Q3
137
15.37M
41.19%
-4.80M
2024Q2
138
16.05M
43.14%
-5.28M
2024Q1
139
16.82M
45.23%
-5.52M
2023Q4
135
18.46M
50.25%
-3.63M
2023Q3
136
18.83M
51.36%
-3.62M
2023Q2
129
19.59M
54.27%
+67.28K
2023Q1
120
15.56M
46.79%
-1.87M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Federated Hermes Global Investment Management Corp.
2.90M
7.42%
--
--
Mar 31, 2025
Kingdon Capital Management, L.L.C.
2.24M
5.73%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
1.66M
4.25%
-4.84K
-0.29%
Mar 31, 2025
Avidity Partners Management LP
1.23M
3.15%
--
--
Mar 31, 2025
AMH Equity, Ltd.
627.04K
1.61%
+985.00
+0.16%
Mar 31, 2025
Acadian Asset Management LLC
443.06K
1.14%
-24.20K
-5.18%
Mar 31, 2025
Geode Capital Management, L.L.C.
419.49K
1.08%
+14.42K
+3.56%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
416.84K
1.07%
-1.71K
-0.41%
Mar 31, 2025
Bridgeway Capital Management, LLC
353.49K
0.91%
-70.00K
-16.53%
Mar 31, 2025
Angulo (Gonzalez David)
323.28K
0.83%
+23.00K
+7.66%
Apr 09, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
占比0%
iShares Micro-Cap ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
公告日期
类型
比率
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
